Recent advances in cancer-associated fibroblast: Biomarkers, signaling pathways, and therapeutic opportunities
Abstract. Anti-cancer therapies usually focus on tumor cells, but non-tumor stromal components in the tumor microenvironment also play vital roles in tumor initiation and progression, which may be the prognostic factors and potential therapeutic targets. Cancer-associated fibroblasts (CAFs) are the...
Main Authors: | Donger Zhou, Lei Zheng, Xiangxiang Pan, Peifang Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2024-03-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003031 |
Similar Items
-
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives
by: Zengli Fang, et al.
Published: (2023-01-01) -
Mitochondrial Base Editing: Recent Advances towards Therapeutic Opportunities
by: Bibekananda Kar, et al.
Published: (2023-03-01) -
Signaling pathways of adipose stem cell-derived exosomes promoting muscle regeneration
by: Aoxuan Zhu, et al.
Published: (2022-11-01) -
Clusterin as a serum biomarker candidate contributes to the lung fibroblasts activation in chronic obstructive pulmonary disease
by: Qiang Zhang, et al.
Published: (2022-05-01) -
Recent advances in signaling pathways related to choroidal neovascularization
by: Bao-Di Deng, et al.
Published: (2019-05-01)